

Recent Posts
- dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
- Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals
- Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors
- Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity
- Talk Radioisotopes: Sigal Kalmanson Cusnir, CEO and Co-Founder, Starget Pharma
Recent Comments
No comments to show.